QFR Assessment and Prognosis After Nonculprit PCI in Patients With Acute Myocardial Infarction.

[1]  Min Chul Kim,et al.  Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial. , 2022, European heart journal.

[2]  C. Don,et al.  2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2021, Journal of the American College of Cardiology.

[3]  P. Serruys,et al.  Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial , 2021, The Lancet.

[4]  G. Chatellier,et al.  Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. , 2021, The New England journal of medicine.

[5]  ShengOlivia R. Liu,et al.  Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study , 2021, The Lancet.

[6]  S. Y. Im,et al.  Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease. , 2020, International journal of cardiology.

[7]  Deepak L. Bhatt,et al.  2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.

[8]  Habib Samady,et al.  Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study , 2019, The Lancet.

[9]  Á. Avezum,et al.  Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2019, The New England journal of medicine.

[10]  Hyuk-Jae Chang,et al.  Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery Disease. , 2019, Journal of the American College of Cardiology.

[11]  J. Escaned,et al.  Diagnostic Agreement of Quantitative Flow Ratio With Fractional Flow Reserve and Instantaneous Wave‐Free Ratio , 2019, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

[12]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[13]  J. Spertus,et al.  Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document , 2018, Circulation.

[14]  J. Leipsic,et al.  Effect of Plaque Burden and Morphology on Myocardial Blood Flow and Fractional Flow Reserve. , 2018, Journal of the American College of Cardiology.

[15]  H. Bøtker,et al.  Lesion-Specific and Vessel-Related Determinants of Fractional Flow Reserve Beyond Coronary Artery Stenosis. , 2018, JACC. Cardiovascular imaging.

[16]  Shengshou Hu,et al.  Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis. , 2017, Journal of the American College of Cardiology.

[17]  F. Neumann,et al.  Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction , 2017, The New England journal of medicine.

[18]  J. Reiber,et al.  Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study. , 2016, JACC. Cardiovascular interventions.

[19]  Laura Mauri,et al.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Journal of the American College of Cardiology.

[20]  Pascal Vranckx,et al.  Standardization of Fractional Flow Reserve Measurements. , 2016, Journal of the American College of Cardiology.

[21]  H. Swanton,et al.  Complete Versus Lesion-Only Primary PCI , 2015, Journal of the American College of Cardiology.

[22]  L. Køber,et al.  Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.

[23]  H. Swanton,et al.  Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease , 2015, Journal of the American College of Cardiology.

[24]  C. Berry,et al.  Randomized trial of preventive angioplasty in myocardial infarction. , 2013, The New England journal of medicine.

[25]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[26]  W. O’Neill,et al.  Multiple complex coronary plaques in patients with acute myocardial infarction. , 2000, The New England journal of medicine.

[27]  Jeroen J. Bax,et al.  Third universal definition of myocardial infarction. , 2012, Circulation.